Home
Kilitch Drugs (india) Ltd PE Ratio

Kilitch Drugs (India) Ltd
NSE: KILITCH
PE
Key Highlights
- The P/E Ratio of Kilitch Drugs (India) Ltd is 27.7 as of 19 Mar 15:30 PM .
- The P/E Ratio of Kilitch Drugs (India) Ltd changed from 147.7 on March 2020 to 42.9 on March 2024 . This represents a CAGR of -21.91% over 5 years.
- The Latest Trading Price of Kilitch Drugs (India) Ltd is ₹ 344.9 as of 19 Mar 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Kilitch Drugs (India) Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Kilitch Drugs (India) Ltd
Company Fundamentals for Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Ltd
NSE: KILITCH
Share Price
Market Price of Kilitch Drugs (India) Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
19 Mar 2025 | 344.9 |
18 Mar 2025 | 336.4 |
17 Mar 2025 | 321.5 |
13 Mar 2025 | 315 |
12 Mar 2025 | 310.55 |
11 Mar 2025 | 306 |
10 Mar 2025 | 306.5 |
07 Mar 2025 | 306.75 |
06 Mar 2025 | 310.5 |
05 Mar 2025 | 308 |
SWOT Analysis Of Kilitch Drugs (India) Ltd
BlinkX Score for Kilitch Drugs (India) Ltd
Asset Value vs Market Value of Kilitch Drugs (India) Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Kilitch Drugs (India) Ltd | 541.01 | 27.73 |
Sun Pharmaceuticals Industries Ltd | 419548 | 35.6 |
Divis Laboratories Ltd | 153385 | 74.2 |
Cipla Ltd | 121845 | 24.4 |
Torrent Pharmaceuticals Ltd | 106118 | 57.0 |
Dr Reddys Laboratories Ltd | 97189 | 18.1 |
Company | |
---|---|
Kilitch Drugs (India) Ltd | 541.01 |
Sun Pharmaceuticals Industries Ltd | 419548 |
Divis Laboratories Ltd | 153385 |
Cipla Ltd | 121845 |
Torrent Pharmaceuticals Ltd | 106118 |
Dr Reddys Laboratories Ltd | 97189 |
PE Ratio of Kilitch Drugs (India) Ltd Explained
₹541.01
Market cap
₹19
Earnings
27.7X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Kilitch Drugs (India) Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Kilitch Drugs (India) Ltd
Historical Revenue, EBITDA and Net Profit of Kilitch Drugs (India) Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Kilitch Drugs (India) Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Kilitch Drugs (India) Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Kilitch Drugs (India) Ltd
About Kilitch Drugs (India) Ltd
- Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe.
- Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables & Ophthalmic, Effervescent tablets & Granules, Tablets & Capsules, OTC range covering varied Nutraceuticals & Cosmetics and Medical devices. The Company is engaged in development, manufacturing and marketing of quality finished dosages.
- The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.
Kilitch Drugs (India) Ltd News Hub
Kilitch Drugs (India) consolidated net profit declines 60.12% in the June 2024 quarter
Net profit of Kilitch Drugs (India) declined 60.12% to Rs 1.34 crore in the quarter ended June 2024
Read more
09 Aug 24
Kilitch Drugs (India) to conduct board meeting
Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 August 2024.
Read more
02 Aug 24
Kilitch Drugs (India) to convene AGM
Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company will be he
Read more
31 Aug 24
Kilitch Drugs (India) announces board meeting date
Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 November 20
Read more
05 Nov 24